Form D · Other Technology
Bioliberty Ltd
Edinburgh, X0 · CIK 0002151818
Offering snapshot reported Oct 26, 2026 · SEC filing
- Reported sold
- $336K Offering amount: $661K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 16, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2026 | Initial | $335,906 | No comparison | 2 | SEC filing |
| Aug 27, 2026 | Initial | $2,947,097 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-602537
Source: Form D, filed Oct 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rowan Armstrong | Director |
| Russell Bailey | Director |
| Conan Bradley | Director |
| Ramy El Madany | Director |
| Barry Hextall | Executive |
| Albert Nicholl | Director |
| Ross O'hanlon | Director |
| David O'reilly | Director |
| Shea Quinn | Director |
| Dana Strauss | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3 F Canning Exchange 10 Canning Street
Edinburgh, X0, EH3 8EG
Edinburgh, X0, EH3 8EG